Targeting the transient group of cells could prevent recurrence of the disease.

Checkpoint inhibition combined with chemotherapy gives patients with triple-negative metastatic breast cancer about two months more time without significant tumor growth, a study finds.

William Halsted’s approach to mastectomy took the medical world by storm at the turn of the last century.

Mice with cancer whose KRAS proteins couldn’t link together had much better survival outcomes than those whose oncogenic mutant paired with wild-type KRAS.

Multidrug combinations lead to better results for cancer patients, but efficiently identifying them is proving difficult.

The immunotherapy, which targets CD22 on cancer cells rather than CD19, might prove useful in patients for whom previous T-cell treatments were unsuccessful. 

Zebrafish larvae transplanted with patients’ tumors respond as their human donors do to chemotherapy.

A new report summarizes what we know about the impacts of marijuana use, as more states have legalized the drug for both medical and recreational purposes.

Vaccine-induced macrophages open a new realm of study into remodeling the immune system to reduce the risk of infections during cancer treatment.